Stockreport

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial

Clearmind Medicine Inc.  (CMND) 
PDF Vancouver, Canada, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech comp [Read more]